Bridgeway Capital Management’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-7,200
Closed -$431K 1345
2021
Q3
$431K Hold
7,200
0.01% 1078
2021
Q2
$488K Hold
7,200
0.01% 1071
2021
Q1
$472K Sell
7,200
-900
-11% -$54K 0.01% 1101
2020
Q4
$456K Buy
8,100
+1,900
+31% +$93.4K 0.01% 981
2020
Q3
$301K Hold
6,200
0.01% 1068
2020
Q2
$345K Buy
6,200
+2,100
+51% +$121K 0.01% 990
2020
Q1
$208K Buy
+4,100
New +$275K ﹤0.01% 1049
2014
Q2
Sell
-23,600
Closed -$906K 1469
2014
Q1
$906K Hold
23,600
0.03% 800
2013
Q4
$763K Buy
23,600
+50
+0.2% +$1.5K 0.02% 855
2013
Q3
$577K Buy
23,550
+650
+3% +$16K 0.02% 957
2013
Q2
$568K Buy
+22,900
New +$501K 0.02% 890

Other funds holding NUVA

Bridgeway Capital Management's NUVA Position: Q4 2021 in Review

Bridgeway Capital Management sold out of NuVasive, Inc. (NUVA) in Q4 2021, closing a stake of 7,200 shares — an estimated $431K sold.

Bridgeway Capital Management first reported a position in NUVA in Q2 2013 and held it in 11 quarters. The position peaked at $906K in Q1 2014. 249 funds tracked by Wall St. Rank hold NUVA as of Q4 2021.

  • Bridgeway Capital Management reported no remaining NuVasive, Inc. position as of Q4 2021 after selling out during the quarter.
  • Bridgeway Capital Management sold 7,200 NuVasive, Inc. shares in Q4 2021, an estimated $431K.
  • Bridgeway Capital Management first reported a position in NuVasive, Inc. in Q2 2013 and held it in 11 quarters.
  • Bridgeway Capital Management's NuVasive, Inc. position peaked at $906K in Q1 2014.
  • 249 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2021.

Based on Bridgeway Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.